×
About 399 results

ALLMedicine™ Ampullary Carcinoma Center

Research & Reviews  197 results

Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cance...
https://doi.org/10.21873/anticanres.14987
Anticancer Research; Utsumi M, Kitada K et. al.

Apr 4th, 2021 - Inflammation-based prognostic scores are proven prognostic biomarkers in various cancers. This study aimed to identify a useful prognostic score for patients with biliary tract cancer (BTC) after surgical resection. This retrospective study recrui...

Ampullary carcinoma of the duodenum: current clinical issues and genomic overview.
https://doi.org/10.1007/s00595-021-02270-0 10.1002/jso.23600 10.1002/jso.21374 10.1007/s00428-002-0625-x 10.1016/j.jamcollsurg.2008.01.028 10.1097/PAS.0b013e3181983ef7 10.1002/jso.24274 10.1016/j.pan.2019.01.019 10.1309/AJCPCTCUQSYI89YT 10.1002/jso.22090 10.1200/JCO.2012.46.8868 10.1371/journal.pone.0065144 10.1097/MPA.0000000000000112 10.1016/j.surg.2015.02.001 10.1038/bjc.2015.172 10.1177/145749691110000205 10.1007/s00428-007-0444-1 10.1007/s11605-010-1156-4 10.1245/s10434-012-2603-0 10.1002/jso.23529 10.1186/s12876-015-0396-x 10.1016/j.humpath.2015.11.009 10.1177/1066896916664987 10.1001/archsurg.138.9.941 10.1001/archsurg.134.5.526 10.1007/s11605-009-1080-7 10.4251/wjgo.v10.i11.370 10.1111/j.1349-7006.1994.tb02077.x 10.1007/s00534-004-0894-7 10.1186/1471-2407-8-170 10.1097/00000658-199807000-00013 10.1097/00000478-200407000-00005 10.1097/PAS.0000000000000230 10.1097/PAS.0000000000000863 10.1097/SLA.0000000000001999 10.1016/j.celrep.2015.12.005 10.1097/01.pas.0000149708.12335.6a 10.1038/modpathol.2016.124 10.1136/gut.22.12.1031 10.1016/S0140-6736(88)91962-9 10.1007/s10350-004-7273-y 10.1002/(SICI)1097-0215(19961104)68:3<305::AID-IJC7>3.0.CO;2-5 10.1016/j.ccell.2015.12.012 10.1038/nature11547 10.1038/modpathol.2015.57 10.4251/wjgo.v4.i3.60 10.1001/jama.2012.7352 10.1245/s10434-017-6025-x 10.1097/00000658-197505000-00005 10.1245/s10434-006-9136-3 10.1097/01.sla.0000167853.04171.bb 10.1016/j.surg.2004.03.010 10.1007/s00268-010-0759-y 10.1159/000370251 10.1016/S0039-6060(97)90048-9 10.1002/bjs.9919 10.3748/wjg.v25.i47.6847 10.1186/s12876-017-0691-9 10.1007/s00464-019-07206-x 10.1016/j.gie.2015.06.027 10.1055/s-2007-1018303 10.1111/hpb.12038 10.3748/wjg.v21.i26.7970 10.1111/j.1440-1746.2008.05578.x 10.1016/j.gie.2007.03.1081 10.1007/s00268-013-1995-8 10.1002/cncr.10831 10.1097/SLA.0b013e318190c53e 10.1097/SLA.0b013e318156eef3 10.1007/s11605-017-3624-6 10.1001/jamasurg.2019.1170
Surgery Today; Okano K, Oshima M et. al.

Apr 2nd, 2021 - Ampullary carcinomas of the duodenum are uncommon. Moreover, the diversity in the clinical outcomes of these patients makes it difficult to interpret previous studies and clinical trial results. The difficulty in proper staging of ampullary carcin...

Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of t...
https://doi.org/10.1016/j.pan.2021.03.005
Pancreatology : Official Journal of the International Ass... Nappo G, Galvanin J et. al.

Apr 2nd, 2021 - Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC), pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been debated and remains unclear. The aims of this study were to evaluate outcomes after pa...

Neoadjuvant therapy versus surgery first for ampullary carcinoma: A propensity score-ma...
https://doi.org/10.1002/jso.26435
Journal of Surgical Oncology; Guo M, Beal EW et. al.

Feb 17th, 2021 - The role of neoadjuvant therapy (NT) for ampullary carcinoma (AC) has not been clearly established. Patients who underwent pancreatoduodenectomy for AC between 2004 and 2016 were identified in the National Cancer Database. Overall survival (OS) wa...

see more →

Clinicaltrials.gov  201 results

Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cance...
https://doi.org/10.21873/anticanres.14987
Anticancer Research; Utsumi M, Kitada K et. al.

Apr 4th, 2021 - Inflammation-based prognostic scores are proven prognostic biomarkers in various cancers. This study aimed to identify a useful prognostic score for patients with biliary tract cancer (BTC) after surgical resection. This retrospective study recrui...

Ampullary carcinoma of the duodenum: current clinical issues and genomic overview.
https://doi.org/10.1007/s00595-021-02270-0 10.1002/jso.23600 10.1002/jso.21374 10.1007/s00428-002-0625-x 10.1016/j.jamcollsurg.2008.01.028 10.1097/PAS.0b013e3181983ef7 10.1002/jso.24274 10.1016/j.pan.2019.01.019 10.1309/AJCPCTCUQSYI89YT 10.1002/jso.22090 10.1200/JCO.2012.46.8868 10.1371/journal.pone.0065144 10.1097/MPA.0000000000000112 10.1016/j.surg.2015.02.001 10.1038/bjc.2015.172 10.1177/145749691110000205 10.1007/s00428-007-0444-1 10.1007/s11605-010-1156-4 10.1245/s10434-012-2603-0 10.1002/jso.23529 10.1186/s12876-015-0396-x 10.1016/j.humpath.2015.11.009 10.1177/1066896916664987 10.1001/archsurg.138.9.941 10.1001/archsurg.134.5.526 10.1007/s11605-009-1080-7 10.4251/wjgo.v10.i11.370 10.1111/j.1349-7006.1994.tb02077.x 10.1007/s00534-004-0894-7 10.1186/1471-2407-8-170 10.1097/00000658-199807000-00013 10.1097/00000478-200407000-00005 10.1097/PAS.0000000000000230 10.1097/PAS.0000000000000863 10.1097/SLA.0000000000001999 10.1016/j.celrep.2015.12.005 10.1097/01.pas.0000149708.12335.6a 10.1038/modpathol.2016.124 10.1136/gut.22.12.1031 10.1016/S0140-6736(88)91962-9 10.1007/s10350-004-7273-y 10.1002/(SICI)1097-0215(19961104)68:3<305::AID-IJC7>3.0.CO;2-5 10.1016/j.ccell.2015.12.012 10.1038/nature11547 10.1038/modpathol.2015.57 10.4251/wjgo.v4.i3.60 10.1001/jama.2012.7352 10.1245/s10434-017-6025-x 10.1097/00000658-197505000-00005 10.1245/s10434-006-9136-3 10.1097/01.sla.0000167853.04171.bb 10.1016/j.surg.2004.03.010 10.1007/s00268-010-0759-y 10.1159/000370251 10.1016/S0039-6060(97)90048-9 10.1002/bjs.9919 10.3748/wjg.v25.i47.6847 10.1186/s12876-017-0691-9 10.1007/s00464-019-07206-x 10.1016/j.gie.2015.06.027 10.1055/s-2007-1018303 10.1111/hpb.12038 10.3748/wjg.v21.i26.7970 10.1111/j.1440-1746.2008.05578.x 10.1016/j.gie.2007.03.1081 10.1007/s00268-013-1995-8 10.1002/cncr.10831 10.1097/SLA.0b013e318190c53e 10.1097/SLA.0b013e318156eef3 10.1007/s11605-017-3624-6 10.1001/jamasurg.2019.1170
Surgery Today; Okano K, Oshima M et. al.

Apr 2nd, 2021 - Ampullary carcinomas of the duodenum are uncommon. Moreover, the diversity in the clinical outcomes of these patients makes it difficult to interpret previous studies and clinical trial results. The difficulty in proper staging of ampullary carcin...

Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of t...
https://doi.org/10.1016/j.pan.2021.03.005
Pancreatology : Official Journal of the International Ass... Nappo G, Galvanin J et. al.

Apr 2nd, 2021 - Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC), pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been debated and remains unclear. The aims of this study were to evaluate outcomes after pa...

Neoadjuvant therapy versus surgery first for ampullary carcinoma: A propensity score-ma...
https://doi.org/10.1002/jso.26435
Journal of Surgical Oncology; Guo M, Beal EW et. al.

Feb 17th, 2021 - The role of neoadjuvant therapy (NT) for ampullary carcinoma (AC) has not been clearly established. Patients who underwent pancreatoduodenectomy for AC between 2004 and 2016 were identified in the National Cancer Database. Overall survival (OS) wa...

see more →

Patient Education  1 results see all →